Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 297.50
Ask: 300.00
Change: -6.00 (-1.98%)
Spread: 2.50 (0.84%)
Open: 313.00
High: 313.50
Low: 296.50
Prev. Close: 302.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Major Interest in Shares

5 May 2010 11:39

RNS Number : 3707L
Oxford Biomedica PLC
05 May 2010
 



For immediate release

5 May 2010

 

Oxford BioMedica Plc

Notification of Major Interest in Shares

 

TR-1: Notifications of Major Interests in Shares

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Oxford BioMedica Plc

 

2. Reason for notification (yes/no)

 

An acquisition or disposal of voting rights

Yes

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An event changing the breakdown of voting rights

 

Other (please specify):______________

 

3. Full name of person(s) subject to notification obligation:

 

Cubana Investments Limited

 

 

4. Full name of shareholder(s) (if different from 3):

 

5. Date of transaction (and date on which the threshold is crossed or reached if different):

 

04 May 2010

 

6. Date on which issuer notified:

 

05 May 2010

 

7. Threshold(s) that is/are crossed or reached:

 

9%

 

8: Notified Details

A: Voting rights attached to shares

 

Class/type of shares

If possible use ISIN code

 

 

 

 

 

GB0006648157

 

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

 

 

Number of shares

 

 

 

 

43,705,280

Number of voting rights

 

 

 

43,705,280

Number of shares

 

 

 

 

48,945,201

Number of voting rights

Percentage of voting rights

 

Direct

 

 

48,945,201

 

Indirect

 

 

Direct

 

 

9.01%

 

Indirect

B: Financial Instruments

 

Resulting situation after the triggering transaction

 

Type of financial instrument

Expiration date

Exercise/ conversion period/date

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

 

 

Total (A+B)

 

Number of voting rights

Percentage of voting rights

48,945,201

9.01%

 

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Proxy Voting:

 

10. Name of proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

 

14 Contact name:

 

Andrew Wood

15. Contact telephone number:

 

01865 783000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLAAMMTMBJMBRM
Date   Source Headline
1st Feb 201710:09 amRNSTotal Voting Rights
25th Jan 20179:02 amRNSDirector/PDMR Shareholding
24th Jan 20174:34 pmRNSDirector Dealings / Market Share Purchase
24th Jan 20179:31 amRNSDirector/PDMR Shareholding
23rd Jan 20179:57 amRNSDirector/PDMR Shareholding
3rd Jan 20179:30 amRNSBlock Listing Return
3rd Jan 20179:28 amRNSTotal Voting Rights
20th Dec 20168:57 amRNSDirector/PDMR Shareholding
12th Dec 201610:52 amRNSBlock listing application
6th Dec 20169:15 amRNSDirector/PDMR Shareholding
5th Dec 201610:25 amRNSFindings Reported by Novartis on CTL-019 at ASH
5th Dec 20169:43 amRNSDirector/PDMR Shareholding
1st Dec 20169:27 amRNSTotal Voting Rights
29th Nov 20167:00 amRNSStrategic Alliance with Orchard Therapeutics
28th Nov 201610:06 amRNSDirector/PDMR Shareholding
8th Nov 20166:28 pmRNSGrant of options (Replacement)
8th Nov 20166:13 pmRNSGrant of options
1st Nov 201610:21 amRNSTotal Voting Rights
25th Oct 20164:40 pmRNSDirector/PDMR Shareholding
10th Oct 20167:21 amRNSPublication of RetinoStat® (OXB-201) Phase I study
6th Oct 20169:24 amRNSHolding(s) in Company
5th Oct 201610:17 amRNSHolding(s) in Company
4th Oct 201611:57 amRNSHolding(s) in Company
4th Oct 20168:16 amRNSAdmission to Trading and Total Voting Rights
29th Sep 201612:27 pmRNSResult of General Meeting and Directors Dealing
26th Sep 201611:00 amRNSDirector/PDMR Shareholding
13th Sep 20163:07 pmRNSPublication of Prospectus
13th Sep 20167:01 amRNSFUNDRAISING OF £10 MILLION
13th Sep 20167:00 amRNSINTERIM RESULTS FOR 6 MONTHS ENDED 30 JUNE 2016
1st Sep 201610:47 amRNSTotal Voting Rights
25th Aug 20162:22 pmRNSDirector/PDMR Shareholding
2nd Aug 20164:35 pmRNSPrice Monitoring Extension
2nd Aug 20169:32 amRNSTotal Voting Rights
28th Jul 20167:00 amRNSManufacturing Approvals and Expansion Completed
25th Jul 20169:56 amRNSDirector/PDMR Shareholding
8th Jul 201612:02 pmRNSPrice Monitoring Extension
4th Jul 20169:14 amRNSBlock Listing Return
4th Jul 20169:12 amRNSTotal Voting Rights
28th Jun 20164:40 pmRNSSecond Price Monitoring Extn
28th Jun 20164:35 pmRNSSecond Price Monitoring Extn
28th Jun 201612:07 pmRNSSecond Price Monitoring Extn
28th Jun 201612:02 pmRNSPrice Monitoring Extension
27th Jun 201610:37 amRNSDirector/PDMR Shareholding
22nd Jun 201612:07 pmRNSSecond Price Monitoring Extn
22nd Jun 201612:02 pmRNSPrice Monitoring Extension
16th Jun 20164:40 pmRNSSecond Price Monitoring Extn
16th Jun 20164:35 pmRNSPrice Monitoring Extension
15th Jun 201612:07 pmRNSSecond Price Monitoring Extn
15th Jun 201612:02 pmRNSPrice Monitoring Extension
7th Jun 20161:14 pmRNSOxford BioMedica Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.